National Institute of Child Health and Human Development; Notice of Closed Meetings, 34948 [06-5470]
Download as PDF
<![CDATA[
34948
Federal Register / Vol. 71, No. 116 / Friday, June 16, 2006 / Notices
comment from the mother of a living
donor and recipient who both
experienced post-transplant
complications asserted that stronger
policies should be developed to ensure
living donor safety.
Conclusion
HRSA has reviewed and considered
each aspect of each comment and has
determined that OPTN living donor
guidelines should be given the same
status of other OPTN policies as
discussed in the Federal Register Notice
published on January 23, 2006. Under
42 CFR 121.4(a)(6), the Secretary directs
the OPTN to develop policies regarding
living organ donors and living organ
donor recipients, including policies for
the equitable allocation of living donor
organs, in accordance with section 121.8
of the final rule. Thus, the OPTN shall
develop such policies in the same
manner, and with the same public
comment process, that it does for
policies on deceased organ donors and
deceased organ donor recipients. Noncompliance with such policies shall
subject OPTN members to the same
consequences as noncompliance with
policies concerning deceased organ
donors and deceased organ donor
recipients developed under the final
rule.
Dated: June 9, 2006.
Elizabeth M. Duke,
Administrator.
[FR Doc. E6–9401 Filed 6–15–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wwhite on PROD1PC61 with NOTICES
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Aug<31>2005
18:25 Jun 15, 2006
Jkt 208001
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Sequencing Centers Review.
Date: July 13, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Hotel Rouge, 1315 16th Street,
NW., Washington, DC 20036.
Contact Person: Rudy O. Pozzatti, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Geonome
Research Institute, National Institutes of
Health, Bethesda, MD 20892. 301–402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: June 12, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5471 Filed 6–15–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Gonadotropin
Inhibitors: A Structural Biology Approach To
Immunocontraception.
Date: July 6, 2006.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD,
Scientist Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892. (301) 435–6884.
ranhandj@mail.nih.gov.
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Global Profiling of
Molecular Errors Associated With Human
Spermatogenic Disorder.
Date: July 6, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD,
Scientist Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892. (301) 435–6884.
ranhandj@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Immunodominant
Ovarian Antigens Involved in Premature
Ovarian Failure.
Date: July 7, 2006.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD,
Scientist Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892. (301) 435–6884.
ranhandj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 12, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5470 Filed 6–15–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 71, Number 116 (Friday, June 16, 2006)]
[Notices]
[Page 34948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5470]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and Human Development; Notice
of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Gonadotropin Inhibitors: A
Structural Biology Approach To Immunocontraception.
Date: July 6, 2006.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD, Scientist Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, NIH, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892. (301) 435-6884.
ranhandj@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Global Profiling of Molecular
Errors Associated With Human Spermatogenic Disorder.
Date: July 6, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD, Scientist Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, NIH, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892. (301) 435-6884.
ranhandj@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Immunodominant Ovarian Antigens
Involved in Premature Ovarian Failure.
Date: July 7, 2006.
Time: 10 a.m. to 11 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Room 5B01, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Jon M. Ranhand, PhD, Scientist Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, NIH, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892. (301) 435-6884.
ranhandj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 12, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5470 Filed 6-15-06; 8:45 am]
BILLING CODE 4140-01-M
